We are pleased to share that the SYNTHIA project has been featured in ICT&health. The article explores how synthetic medical data can be used to advance healthcare research while avoiding the privacy and compliance challenges of handling real patient information, with SYNTHIA emerging as a pioneer in this field.
The article titled "Synthetic Data: Medical research without GDPR headaches?" states:
Developing new methods for early Alzheimer’s detection or innovative treatments for various cancers requires vast amounts of data. Yet strict data protection regulations often prevent researchers from using even available datasets. Many scientists avoid working with patient data altogether, fearing legal risks. A promising solution lies in synthetic data generated by artificial intelligence. In Europe, the SYNTHIA project is leading the way.
SYNTHIA: A European step forward
Launched in late 2024, the SYNTHIA project is the most ambitious European initiative focused on synthetic data for healthcare. The project runs until 2029 and is funded by the EU’s Innovative Health Initiative with a budget of 22.4 million euros. Its aim is to build a federated platform that enables researchers to generate, evaluate and use synthetic patient data in a secure and ethical way.
SYNTHIA focuses on six diseases: lung and breast cancer, multiple myeloma, diffuse large B-cell lymphoma, Alzheimer’s disease and type 2 diabetes.
.png)
ICT&health Global is the authoritative platform where international health leaders, innovators and policymakers connect to shape the future of care. The platform delivers strategic insight into the digital and systemic transformation of healthcare, through trustworthy journalism, real-world examples, and collaboration with leading voices across the global health ecosystem.
